BCN-exo-PEG3-maleimide?Chemical Structure(2919127-00-5)
- Name: BCN-exo-PEG3-maleimide?Chemical Structure
- Synonyms:BCN-exo-PEG3-maleimide?Chemical Structure;5,8,11-Trioxa-2,14-diazaheptadecanoic acid, 17-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-15-oxo-, (1α,8α,9α)-bicyclo[6.1.0]non-4-yn-9-ylmethyl ester;exo-BCN-PEG3-NHCO-Maleimide
- Molecular Formula:C26H37N3O8
- Molecular Weight:519.59
- CAS Registry Number:2919127-00-5
- EINECS:
- Melting Point:734.529±60.00 °C(Press: 760.00 Torr)(predicted)
- Water Solubility:
Other Product
- 2918768-06-4/porcine Acetate（66641-26-7 Free base）
- 2918768-10-0/Abl Cytosolic Substrate acetate
- 2918768-25-7/Eledoisin Related Peptide 2TFA
- 2918768-26-8/Acetyl Tetrapeptide5 acetate,Acetyl Tetrapeptide 5 acetate
- 2918768-27-9/C Reactive Protein (CRP) 77 82 acetate,CReactive Protein (CRP) 7782 acetate
- 2918768-28-0/[Met5]-Enkephalin, amide TFA
- 2918768-29-1/SLLK-NH2, Control Peptide for TSP1 Inhibitor
- 2918768-30-4/SLLK-NH2, Control Peptide for TSP1 Inhibitor acetate
- 2918768-31-5/[Sar1, Ile8]-Angiotensin II TFA
- 2918771-38-5/CReactive Protein (CRP) 201206 acetate,C Reactive Protein (CRP) 201 206 acetate
- 2918771-43-2/H PRO HIS CYS LYS ARG MET OH acetate,HPROHISCYSLYSARGMETOH acetate
- 2918771-49-8/[D Arg1,D Phe5,D Trp7,9,Leu11] Substance P acetate,[D-Arg-1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate,[DArg1,DPhe5,DTrp7,9,Leu11]Substance P acetate
- 2918771-52-3/Lyn peptide inhibitor acetate
- 2918851-48-4/4-Isopropoxy-3,5-diisopropyl-benzoic acid
- 2918900-95-3/4-(benzyloxy)-2,5-dichloropyridine
- 2918976-04-0/2-(15-chloro-14-fluoro-5-[(4-methoxyphenyl)methyl]-9-methyl-8-oxo-2,5,9,12,16-pentaazatetracyclo[8.8.0.0^{2,7}.0^{13,18}]octadeca-1(10),11,13,15,17-pentaen-4-yl)acetonitrile
- 2918995-65-8/Oseltamivir Impurity 152
- 2919064-81-4/1,3-Benzenediamine, N1,N1-bis[4-(1,1-dimethylethyl)phenyl]-
- 2919113-04-3/NA
- 2919127-00-5/BCN-exo-PEG3-maleimide?Chemical Structure
- 2919213-53-7/Methanesulfonamide, N-[3-[[(2-chloro-5-iodo-4-pyrimidinyl)amino]methyl]-2-pyrazinyl]-N-methyl-
- 2919-29-1/Estra-1,3,5(10),8-tetraen-17-one, 3-methoxy-, cyclic 1,2-ethanediyl acetal
- 2919324-15-3/Osimertinib Impurity 14
- 2919324-18-6/Osimertinib Dimer Impurity 2
- 2919374-62-0/4-Chloro-7-methoxy-2-methylpyrido[2,3-d]pyrimidine
- 2919514-15-9/(5-bromo-1H-indol-2-yl)(1H-imidazol-1-yl)methanone
- 2919563-38-3/(S)-2-((8S,10S,13S,14S,17R)-10,13-dimethy1-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H- cyclopenta[alphenanthren-17-yl)propanal
- 2919582-83-3/Propane, 1,1,1,3,3,3-hexafluoro-2-[2-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]ethoxy]-
- 2919702-80-8/2,2'-((2Z,2'Z)-((12,13-bis(2-heptylundecyl)-3,9-heneicosyl-12,13-dihydro-[1,2,5]thiadiazo[3,4-E]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-G]thieno[2',3':4,5]thieno[3,2-B]indole-2,10-diyl)bis(formylsulfoxide))bis(5,
- 29197-46-4/2-Pyridin-2-yl-quinoline-4-carboxylic acid amide